Helicobacter pylori as a vaccine delivery system

Helicobacter

Volumn 12, Issue SUPPL. 2, 2007, Pages 75-79

  Marshall, Barry ^a   Schoep, Tobias ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Delivery; Pylori; Recombinant; Vaccine

Indexed keywords

HELICOBACTER PYLORI VACCINE; MACROLIDE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; HELICOBACTER PYLORI; IMMUNE SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STOMACH MUCOSA;

BACTERIAL VACCINES; GENETIC VECTORS; HELICOBACTER PYLORI; HUMANS; VACCINES, ATTENUATED;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 35948986780     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00568.x     Document Type: Review

References (34)

1. Soto G, Bautista CT, Roth DE, et al. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis 2003 188 : 1263 75.
2. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995 267 : 1655 8.
3. Marchetti M, Rossi M, Giannelli V, et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 1998 16 : 33 7.
4. Yamaguchi H, Osaki T, Taguchi H, et al. Effect of bacterial flora on postimmunization gastritis following oral vaccination of mice with Helicobacter pylori heat shock protein 60. Clin Diagn Lab Immunol 2003 10 : 808 12.
5. Skene C, Young A, Every A, Sutton P. Helicobacter pylori flagella: antigenic profile and protective immunity. FEMS Immunol Med Microbiol 2007 50 : 249 56.
6. Czinn SJ, Cai A, Nedrud JG. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 1993 11 : 637 42.
7. Lee CK, Soike K, Giannasca P, et al. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine 1999 17 : 3072 82.
8. Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 2001 69 : 3581 90.
9. Michetti P, Kreiss C, Kotloff KL, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 1999 116 : 804 12.
10. Metzger WG, Mansouri E, Kronawitter M, et al. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 2004 22 : 2273 7.
11. Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007 445 : 915 8.
12. Ghose C, Perez-Perez GI, van Doorn LJ, Dominguez-Bello MG, Blaser MJ. High frequency of gastric colonization with multiple Helicobacter pylori strains in Venezuelan subjects. J Clin Microbiol 2005 43 : 2635 41.
13. Kirschner DE, Blaser MJ. The dynamics of Helicobacter pylori infection of the human stomach. J Theor Biol 1995 176 : 281 90.
14. Dominici P, Bellentani S, Di Biase AR, et al. Familial clustering of Helicobacter pylori infection: population based study. BMJ 1999 319 : 537 40.
15. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991 13 : 42 59.
16. Curtiss R, 3rd. Bacterial infectious disease control by vaccine development. J Clin Invest 2002 110 : 1061 6.
17. Alonso LJ, Pascual MG, Perez AR, Hernandez EA, Busquets EB, Fonseca ME. Helicobacter pylori infection in a group of HIV/AIDS patients. Rev Cubana Med Trop 2001 53 : 199 203.
18. Azuma T, Ohtani M, Yamazaki Y, Higashi H, Hatakeyama M. Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology 2004 126 : 1926 7.
19. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996 91 : 949 53.
20. Takata T, Fujimoto S, Anzai K, et al. Analysis of the expression of CagA and VacA and the vacuolating activity in 167 isolates from patients with either peptic ulcers or non-ulcer dyspepsia. Am J Gastroenterol 1998 93 : 30 4.
21. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. Jama 2004 291 : 187 94.
22. Delport W, van der Merwe SW. The transmission of Helicobacter pylori: the effects of analysis method and study population on inference. Best Pract Res Clin Gastroenterol 2007 21 : 215 36.
23. Al-Marhoon MS, Nunn S, Soames RW. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness. J Gastroenterol Hepatol 2005 20 : 1246 52.
24. Allen LA. Phagocytosis and persistence of Helicobacter pylori. Cell Microbiol 2007 9 : 817 28.
25. Drakes ML, Czinn SJ, Blanchard TG. Regulation of murine dendritic cell immune responses by Helicobacter felis antigen. Infect Immun 2006 74 : 4624 33.
26. D'Elios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, T cells and cytokines: the "dangerous liaisons." FEMS Immunol Med Microbiol 2005 44 : 113 9.
27. Portal-Celhay C, Perez-Perez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci (Lond) 2006 110 : 305 14.
28. Nurgalieva ZZ, Conner ME, Opekun AR, et al. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun 2005 73 : 2999 3006.
29. Gebert B, Fischer W, Haas R. The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol 2004 152 : 205 20.
30. Han YH, Liu WZ, Shi YZ, et al. Comparative genomics profiling of clinical isolates of Helicobacter pylori in Chinese populations using DNA microarray. J Microbiol 2007 45 : 21 8.
31. Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 2005 21 : 653 9.
32. Orsini B, Ciancio G, Surrenti E, et al. Serologic detection of CagA positive Helicobacter pylori infection in a northern Italian population: its association with peptic ulcer disease. Helicobacter 1998 3 : 15 20.
33. Palli D, Menegatti M, Masala G, et al. Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy. Aliment Pharmacol Ther 2002 16 : 1015 20.
34. Frey J. Biological safety concepts of genetically modified live bacterial vaccines. Vaccine 2007 25 : 5598 605.